Fig. 1From: RNA disruption indicates CHOP therapy efficacy in canine lymphomaRNA disruption during CHOP therapy for dogs separated by immunophenotype. RNA disruption during CHOP therapy for dogs separated by immunophenotype A) dogs that had B cell lymphoma (n = 19) and B) dogs that had T cell lymphoma (n = 4). Five dogs were found to have inadequate samples at all time-points and were therefore not included; 13 dogs did not have their tumour immunophenotype determined. Each line represents an individual animalBack to article page